Posts by DAY Vision
Physician Insight for Patients: Dr. Vincent Reid – MarginProbe® Shrinks Positive Margin Rates and Tissue Volume Removed for Both Invasive and DCIS Breast Cancers
MarginProbe® Gives Patients the Best Chance for Only One Lumpectomy Procedure for Both Invasive and DCIS Breast Cancers
Read MorePhysician Insight for Patients: Dr. Melanie Friedlander – MarginProbe® Greatly Enhances Outcomes with DCIS Breast Cancer Surgery
Dr. Melanie Friedlander, South Bay Surgeons: Specializes in General Surgery, Breast Surgery, Advanced Laparoscopic Surgery, Thyroid and Parathyroid surgery.
Read MoreMarginProbe® Shrinks Positive Margin Rates and Tissue Volume Removed for Both Invasive and DCIS Breast Cancers
Dr. Reid is a firm believer in the success of MarginProbe in improving the results of breast cancer surgery.
Read MoreSurgeon Spotlight: Dr. Jeffrey Falk – Early Study Data Supports the Value of MarginProbe® in Getting All the Cancer in the First Lumpectomy Surgery
Dr. Jeffrey Falk is a surgical oncologist focusing primarily on breast cancer since starting his practice in 2001. He performs 200-350 breast cancer surgeries annually and has a special interest in research and clinical trials for breast cancer treatments.
Read MoreMapping Breast Tissue Types by Miniature Radio-Frequency Near-Field Spectroscopy Sensor in Ex-Vivo Freshly Excised Specimens
[vc_row][vc_column][vc_column_text]Zvi Kaufman,1,7 Haim Paran,1 Ilana Haas,1 Patricia Malinger,1 Tania Zehavi,2 Tamar Karni,3 Izhak Pappo,3 Judith Sandbank,4 Judith Diment,5 and Tanir Allweis6 View the study by clicking here.[/vc_column_text][/vc_column][/vc_row]
Read More